13.8% Scalp Trade Gain on LAVA Therapeutics (LVTX) - Use MAVOL + Bull/Bear Strength

Another quick scalp trade using MAVOL and Bull/Bear strength on $LAVA Therapeutics N.V.(LVTX)$

LVTX was the stock pick by A.I. for 02 June 2023. You can refer to the previous article here: Today(02 Jun) Stock Pick From A.I. model - LAVA Therapeutics N.V. (LVTX)

I was monitoring this stock in premarket and decided to only go in once market open by following my trading plan using MAVOL.

Check Entry Point using MAVOL

I begin to see that the MAVOL5 is greater than MAVOL10 at around 9.30am(EST). I think it is a good time to enter@$2.24.

This is not the lowest price to enter, but it works just fine.

For the exit price I would use Trading View Bull/Bear Power and MAVOL for confirmation.

Plan and Exit using MAVOL and Bull/Bear Power

As I have done and explained before in my previous article, I look for Bull strength when planning for exit price and point.

Today, LVTX is having lots of Bear strength, but a Bull strength appear at around 9.55am(EST).

So I look for MAVOL to have a confirmation that this would be a good exit price and it is within my gain target of approx. 30 cents.

So manage to exit with 13.8%

Summary

This trade require me to monitor the stocks during premarket and then plan for the entry, as there was a downtrend detected before market open at 9.30am(EST).

This is where patience and calmness comes in to allow us to stay focused to find the entry price.

Appreciate if you could share your thoughts in the comment section whether you also traded on LVTX on 02 June 2023?

Do like, share and comment on this article if you find this trading thought useful.

@TigerStars @Daily_Discussion appreciate if you could feature this article so that fellow tiger would benefit from my investing and trading thoughts.

Disclaimer: The analysis and result presented does not recommend or suggest any investing in the said stock. This is purely for Analysis.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment6

  • Top
  • Latest
  • MaudNelly
    ·2023-06-03

    The RSI is currently at 70.00, which is overbought. This suggests that the stock is due for a correction.

    Reply
    Report
  • AndreaClarissa
    ·2023-06-03

    LVTX is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer.

    Reply
    Report
  • Guy
    ·2023-06-03

    The technical indicators suggest that LVTX is due for a correction in the coming months.

    Reply
    Report
  • Newnew
    ·2023-06-04
    Hi
    Reply
    Report
  • Nggimseng
    ·2023-06-04
    Nice
    Reply
    Report
  • YueShan
    ·2023-06-03
    ok
    Reply
    Report